Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Major and Mid-Tier REE Processors Request High-Grade Samples

Defense Metals Corp. ( TSX-V:DEFN / OTCQB:DFMTF / FSE:35D/ Forum ) announced that it has recently been notified by Welsbach Holdings Pte Ltd. that is has received requests from two interested third-party Rare Earth Element processors for samples of high-grade RE...
Featured Submission | March 23, 2021 |

Crude Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life

Saudi Arabia enhanced their commitment to OPEC+ supply cuts as the Kingdom said they'd shut production of additional 1 million barrels of crude oil per day next month. Most of the OPEC+ countries have already come close to compliance with the deal that took effect this mo...
Streetwise Reports | May 22, 2020 |

Asian Shares Boosted by Fed Signals; Trump to Meet with Top Advisors over Tariffs

U.S. President Donald Trump is expected to meet with top trade advisors on Thursday to discuss planned December 15 tariffs on some $160 billion in Chinese goods, three sources familiar with the plans said, according to Reuters, as markets braced for potential negative impacts...
FX Empire | December 12, 2019 |

The Duel Between Johnson and Parliament. Will Gold Win?

Boris Johnson struggles to push the Brexit agreement through the British Parliament. For it can bite back! Who wins this battle? One could hope that gold, but this is not so certain… Johnson’s Struggle, Explained On Thursday, the breaking news came ...
Arkadiusz Sieron | October 23, 2019 |

Addressing the risk in centralized exchanges with Bitshare technology!

We are living in a world panning towards the digital aspects at a rapid pace. In order to stay in the game we have to be familiar with it. Cryptocurrency trading is one of the latest forms of currency trading done by most of the people in the present times. Since cryp...
Ved Prakash | October 22, 2019 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Has the entire market been brought down by the COVID-19 coronavirus pandemic? Not exactly. While most sectors have been battered by the economic downturn brought by the outbreak, a few stocks have not only evaded the damage, they’ve benefited. As the ...
Omri Wallach | March 18, 2020 |

McAfee (MFE): Bullish sentiment, poor stock performance

Shares of security software concern McAfee Inc. ( NYSE: MFE , Stock Forum ) have been far from impressive this year. The stock has underperformed the struggling S&P 500 Index (SPX) by roughly 17% on a relative-strength basis during the past 60 trading days. What's more, M...
Joseph Hargett | October 28, 2012 |

AOL, Inc. (AOL): Can it fly in the face of skepticism?

Late last week, analysts at Macquarie launched coverage of AOL, Inc. ( NYSE: AOL , Stock Forum ) with a "neutral" rating and a $27 price target, essentially implying that they don't expect the stock to move much higher in the near future. Nevertheless, unenthusiastic ra...
Andrea Kramer | October 28, 2012 |
1 2 3 4 5 6 7 8 9 10 ...